Eleonora E. Cocco
Cagliari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 288 publications
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 04, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 02, 2026
Selective taste impairment in relapsing-remitting Multiple Sclerosis and Supervised Learning - driven diagnostic classification.
Journal: Multiple sclerosis and related disorders
Published: June 01, 2026
Corrigendum to "Treatment discontinuation in older patients with multiple sclerosis" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106741].
Journal: Multiple sclerosis and related disorders
Published: May 14, 2026
Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.
Journal: The journal of headache and pain
Published: May 10, 2026
Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.
Journal: Drugs - real world outcomes
Published: May 07, 2026
Integrating peripheral immune control and brain health in the multiple sclerosis continuum.
Journal: Lancet (London, England)
Published: April 13, 2026
Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.
Journal: Frontiers in neurology
Published: March 13, 2026
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.
Journal: Neurology and therapy
Published: February 16, 2026
EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis: Evidence From Integrated Viral and Host Analyses.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 29, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.
Journal: Journal of neurology
Published: December 05, 2025
Last Updated: 09/26/2026